Denali Therapeutics's total assets for Q1 2025 were $1.27B, a decrease of -7.48% from the previous quarter. DE:4DN total liabilities were $148.66M for the fiscal quarter, a 2.88% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.